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Introduction
Acute coronary syndrome (ACS), including myocardial 
infarction (MI), is a costly condition and the leading 
cause of mortality in both women and men throughout 
the world.1,2 The incidence of MI is constantly increasing 
worldwide, mostly due to population aging and sedentary 
lifestyle.3,4 Many risk factors, directly or indirectly, may 
affect the outcomes of patients with MI.5 The outcomes 
disparity between women and men after acute myocardial 
infarction (AMI) has been reported frequently but with 
a wide variety in different ethnic and demographic 
groups.5-9 The reasons for the sex-based differences have 
not been clear yet, though, the known risk factors for MI 
such as diabetes mellitus (DM), hypercholesterolemia, 
and hypertension (HTN) in women are more frequent 
than men.10-12 After adjustment for possible confounders 
such as age and other risk factors, some researchers found 
no differences in the mortality rate between men and 
women,9,12,13 while some others showed that mortality 
remained higher in women.14,15 Hence, female gender 
might be a potential risk factor for mortality after acute 
MI which needs more investigation.16
The aim of this study was to evaluate the baseline and 
clinical characteristics of patients who died after ST-
segment elevation myocardial infarction (STEMI). In 
addition, we investigated whether potential disparity in 
mortality between women and men with STEMI could be 
explained by gender as an independent risk factor. 
Materials and Methods 
Study population 
This study is a part of an ongoing registry of consecutive 
patients with STEMI in Imam Ali Cardiovascular Center, 
Kermanshah University of Medical Sciences (KUMS). 
This is the main cardiovascular center in western Iran 
covering about two millions population mostly Kurdish 
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Introduction: This study aimed to evaluate the in-hospital mortality of patients with ST-segment 
elevation myocardial infarction (STEMI), according to gender and other likely risk factors.
Methods: This study reports on data relating to 1,484 consecutive patients with STEMI registered from 
June 2016 to May 2018 in the Western Iran STEMI Registry. Data were collected using a standardized 
case report developed by the European Observational Registry Program (EORP). The relationship 
between in-hospital mortality and potential predicting variables was assessed multivariable logistic 
regression. Differences between groups in mortality rates were compared using chi-square tests and 
independent t-tests. 
Results: Out of the 1484 patients, 311(21%) were female. Women were different from men in terms of 
age (65.8 vs. 59), prevalence of hypertension (HTN) (63.7% vs. 35.4%), diabetes mellitus (DM) (37.7% 
vs. 16.2%), hypercholesterolemia (36.7% vs. 18.5%) and the history of previous congestive heart failure 
(CHF) (6.6% vs. 3.0%). Smoking was more prevalent among men (55.9% vs. 13.2%). Although the 
in-hospital mortality rate was higher in women (11.6% vs. 5.5%), after adjusting for other risk factors, 
female sex was not an independent predictor for in-hospital mortality. Multivariable analysis identified 
that age and higher Killip class (≥II) were significantly associated with in-hospital mortality rate.
Conclusion: In-hospital mortality after STEMI in women was higher than men. However, the role of 
sex as an independent predictor of mortality disappeared in regression analysis. The gender based 
difference in in-hospital mortality after STEMI may be related to the poorer cardiovascular disease 
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with Caucasian race. Data adjudicated by the standards of 
the European Observational Research Program (EORP). 
Also we used the Standard for Reporting Qualitative 
Research (SRQR) guidelines.
Between July 1, 2017, and May 1, 2018, we evaluated 
patients admitted to the center with a presumed diagnosis 
of STEMI. One criterion for inclusion in the study was 
age ≥18 years old. Another inclusion criterion was the 
diagnosis of STEMI accompanied by the following criteria 
was required: chest pain or equivalent symptoms of 
more than 20 minutes duration within the last 24 hours 
before admission and, electrocardiographic changes 
consistent with new or presumed new ST-segment 
elevations or left bundle branch block, according to third 
universal definition of myocardial infarction defined 
by the European Society of Cardiology/ACCF/AHA/
World Heart Federation Task Force for the Universal 
Definition of Myocardial Infarction.17 STEMI must be 
primary diagnosed by the emergency medical doctors. 
Data collection and validation of the diagnosis was then 
supervised by a physician who was responsible for the 
quality control of the project.
Patients were excluded from the study if they developed 
STEMI after admission in the hospital, or developed 
STEMI after percutaneous coronary angioplasty or 
coronary bypass surgery and/or hospitalized in another 
hospital more than 24 hours before coming to Imam 
Ali hospital, or who did not sign the consent form to 
participate in the study.
Data collection
Using case report forms, data were collected by a nurse 
and a research assistant working in the Kermanshah 
Cardiovascular Research Center (KCRC), who were 
trained in uniform protocols for patient entry and 
data gathering. Case report form was developed by the 
EORP. All completed case report forms were verified 
and checked for errors by the quality control physician 
before submission for final analysis, and then forwarded 
online to the EORP website. We used patients’ national 
identification numbers to avoid duplicate admissions to 
the registry. The collected data included demographic 
characteristics (e.g. age), clinical histories (e.g. previous 
myocardial infarction), admission process (e.g. presenting 
symptoms), biochemical and electrocardiographic 
findings (e.g. blood sugar), treatment procedures (e.g. 
percutaneous coronary intervention, PCI), in-hospital 
outcomes (e.g. vital status). Standardized definitions of 
all variables (e.g. clinical diagnoses) were used. Likewise, 
mortality data (in-hospital) were obtained for all included 
cases.
Statistical methods 
Baseline data including demographic characteristics 
were compared between men and women. Data were 
described using mean ± standard deviation (SD) if they 
were normally distributed; otherwise, frequencies and 
percentages were reported. Differences between subgroups 
were assessed using independent t tests for continuous 
and normally distributed variables and chi-square (or 
Fisher exact tests) for other variables. We compared the 
in-hospital mortality rates among women and men and 
assessed the independent role of sex in patients’ mortality 
using multivariable logistic regression models. Odds ratios 
(ORs) and 95% confidence Intervals (CIs) were calculated. 
The body mass index (BMI) ≥25, HTN, DM, current 
smoking, hypercholesterolemia, congestive heart failure 
(CHF), Killip class (at first presentation) ≥ II, symptom-
to-balloon (STB) time> 360 minutes and door-to-balloon 
(DTB) time > 90 minutes (18) used as covariates, while 
the dependent variable was in-hospital mortality. A test 
was considered statistically significant if the probability 
value (P value) was less than 0.05. The Statistical Package 
for Social Science (SPSS) software, version 23 (IBM Corp., 
Armonk, NY USA) was used for analyzing data. 
Definition
STB time was defined as the time between the onset of 
symptoms to first balloon inflation or first device delivery 
in the culprit vessel.
DTB time was defined as the time between patient’s 
arrival at the PCI hospital and the first balloon inflation 
or first device delivery in the culprit vessel.
Results 
During 20 months, a total of 1484 patients, 1173 (79%) 
men, and 311 (21%) women met the inclusion criteria for 
this study. A significant difference in presenting clinical 
characteristics based on sex was observed. Women 
were, on average, older than men patients: the mean age 
of the women was 65.79 ± 11.34 years, whereas for the 
men was 59.04 ± 12.39 years (P = 0.02). The prevalence 
of hypercholesterolemia, DM, HTN and prior CHF 
was significantly higher in women compared to men, 
whereas more men were current smoker (Table 1). There 
was no statistically significant difference in the Killip 
classifications ≥П between men and women. 
Primary PCI was performed for 878 patients (59.2%), 
697 men (59.4%) and 181 (58.2%) women. The median 
DTB time and STB time (or treatment delay) were slightly 
longer in women than men, but the differences were not 
statistically significant (P ≥ 0.05) (Table 1).
The mean age of patients, at death, was 66.11±11.42 for 
men vs 67.36 ± 9.69 for women. In-hospital mortality rates 
(death before discharge from hospital) were 5.5% (64 out 
of 1173) for men and 11.6% (36 out of 311) for women 
(P = 0.001). Other sex-based differences in personal and 
clinical characteristics of patients were shown in Table 1. 
The role of sex in in-hospital mortality from STEMI was 
further examined using logistic regression model. The sex-
based difference in the mortality rates was disappeared in 
regression analysis after adjustment for the explanatory 
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variables listed in Table 1 (OR 0.896, 95% CI 1.51- 1.73, 
P = 0.77).
Factors contributing to in-hospital mortality were 
analyzed separately for women and men. For both sexes, 
the most important factor that increased in-hospital 
mortality was Killip class≥ II (OR 21.94, 95% CI 1.28- 
373.73, P = 0.03) for women vs. (OR 9.71, 95% CI 2.55- 
36.92, P = 0.001) for men. Age was significantly associated 
with the in-hospital mortality in men (OR: 1.05, 95% CI 
1.00-1.12, P = 0.04, but not in women (OR: 1.00 (0.91-
1.10, P =0.92) (Table 2).
Discussion 
The results of this study illustrated that, in western Iran, 
women who presented with STEMI were significantly 
older and had higher prevalence of cardiovascular risk 
factors i.e. diabetes, hypercholesterolemia, HTN, previous 
CHF, but were less likely to be current smokers compared 
to their men counterparts. Although STEMI was managed 
similarly in both sexes, the in-hospital mortality rate for 
women was two times more than men. However, after 
adjustment for other characteristics such as DM and 
HTN, early mortality was similar for women and men. 
The fact that women present at an older age in the 
current study is consistent with the findings from other 
studies which have reported a mean age range of 58.8 to 
60.9 years for men and 65.5 to 67.5 years for women.6,10,18,19 
Furthermore, the higher incidences of DM, HTN, 
hypercholesterolemia, and prior CHF in women have 
been described in previous observations.20,21 Also, an 
international study reported that women were significantly 
older than men at the time of STEMI and had higher rates 
of HTN, DM, previous CHF, and hypercholesterolemia.22 
Likewise, Birkemeyer et al reported that women were 
significantly older, with a higher prevalence of HTN and 
DM, and men were more likely to be current smokers.23
Also, consistent with some other reports,24,25 this 
study found no significant differences in treatment with 
primary PCI for women and men; however, DTB and 
STB were delayed slightly in women compared to men. 
These results support the findings of previous studies that 
women typically experienced a delay in DTB and STB.26 
In fact, the potential reasons why women delay in seeking 
treatment may be due to their unawareness of cardiac 
disease symptoms or imputing their symptoms to cardiac 
causes.27 Patients education campaigns and programs, 
especially those targeted the women, can be cost-benefit 
in improving women’s awareness. Other reasons could 
be that women, particularly in developing countries, are 
often dependent to men financially, and in some societies 
the decision to seek treatment for women is made by 
men.28
In this study, although women’s mortality was higher 
than men, sex was not an independent predictor of in-
hospital mortality at multivariate analysis. This result also 
concurs with the findings of previous studies. Barbosa et 
al reported that despite a high in-hospital mortality rate 
Table 1. The characteristics of patients with STEMI stratified by sex
Variable Men (n=1173) Women (n=311) P value
Age (y)* 59.04±12.39 65.79±11.34 0.02
BMI (kg/m2)* 25.97±3.73 26.84±4.30 0.001
Current smoker 655 (55.9) 41 (13.2) 0.001
DM 187 (16.2) 114 (37.7) 0.001
Hypercholesterolemia 208 (18.5) 110 (36.7) 0.001
HTN 410 (35.4) 195 (63.7) 0.001
Prior CHF 33 (3.0) 18 (6.6) 0.001
Killip class ≥П 99 (8.0) 25 (7.8) 0.89
Primary PCI performed 697 (59.40) 181 (58.20) 0.50
DTB Time (min) 111.58±120.30 126.86±144.93 0.49
STB Time (min) 250.30±423.70 289.83±290.40 0.86
BMI, body mass index;  CHF, congestive heart failure;  PCI,  percutaneous 
coronary intervention; DTB, Door-to-Balloon; STB, Symptom-to-balloon; 
DM,  diabetes mellitus.
* Continuous variables expressed as mean ± SD, otherwise No. (%).
Table 2. Multivariate analysis of in-hospital mortality according to sex
Risk factor 
Male ( n=64) Female ( n=36)
OR (95 % CI P value OR (95 % CI P value
Age 1.05 (1.00-1.12) 0.04 1.00 (0.91-1.10) 0.92
BMI 1.51 (0.41-5.50) 0.53 1.37(0.18-10.54) 0.75
Current smoker 0.93 (0.25-3.37) 0.91 0.32 (0.01-6.54) 0.46
DM 1.33 (0.25-7.04) 0.73 0.47 (0.04-5.15) 0.54
Hypercholesterolemia 0.31 (0.03-2.80) 0.30 3.29 (0.41-26.04) 0.25
HTN 1.61 (0.45-5.71) 0.45 0.46 (0.06-3.30) 0.44
Previous CHF 0.00 (0.00-0.01) 0.99 2.71 (0.17-42.91) 0.47
Killip class≥ П 9.71 (2.55-36.92) 0.001 21.94 (1.28-37.73) 0.03
DTB time 0.80 (0.23-2.07) 0.73 2.90 (0.27-30.33) 0.37
STB time 3.00 (0.72-12.40) 0.12 0.78 (0.06-9.18) 0.85
N, number; OR, odd ratio; CI, confidence interval; BMI, body mass index;  CHF, congestive heart failure;  DTB, door-to-balloon; STB, symptom-to-
balloon; DM,  diabetes mellitus.
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among women, sex was not an independent predictor 
of death in STEMI.6 Norris and colleagues found that 
compared to men, women with STEMI showed a 
higher rate of in-hospital mortality. They attributed this 
difference to women’s older age, sex clinical severity, 
and more comorbidities.29 Investigating 1548 cases of 
STEMI, De Luca and colleagues reported that female sex 
was not an independent prognostic factor of in-hospital 
mortality.30 In our study, the higher mortality reported 
among women may be due to their significantly higher 
rates of comorbidities, higher baseline risks, older age, and 
longer DTB and SBT, not associated to sex alone, which 
is consistent with the results of earlier studies.31,32 Indeed, 
poorer risk profile increases in-hospital mortality rates, 
but the risk of mortality remain the same for both genders 
when other factors are adjusted for.33
Nevertheless, some researchers have reported different 
results. For instance, Benamer et al described the results 
of a large French STEMI registry in which short term (in-
hospital) mortality was higher in women and the impact 
of female sex on the mortality rate was significant.20 Also, 
Hersi and colleagues’ survey in Saudi Arabia showed 
that female gender was an independent risk factor for 
in-hospital mortality in STEMI.24 Likewise, in a study 
conducted by Lawesson et al, female sex was independently 
linked to higher in-hospital mortality.34 Differences in 
inclusion criteria and patients’ selection, sample size, 
clinical and socio-demographic characteristics, and 
treatment strategies might unfold these different results. 
In addition, we found that Killip class ≥II and age were 
significant independent predictors of in-hospital mortality 
in both genders the results that are consistent with 
findings of pervious research. Reporting the short term 
mortality in a population of 1548 STEMI patients treated 
with primary PCI, De Luca et al found that Killip class ≥ 
II was associated with higher in-hospital mortality rates 
in both genders.30 This conclusion was also confirmed 
by DeGeare and colleagues who studied 2654 cases of 
AMI and found that higher Killip class was associated 
with greater in-hospital mortality rates in both genders.35 
Similarly, El-Menyar et al reported that Killip class≥ II was 
an independent predictor of in-hospital mortality rate in 
the STEMI patients.36 
Furthermore, our results demonstrated that old age 
was independently related to higher in-hospital mortality 
in men. This result is consistent with the finding of 
Waldecker et al, who showed that male patients had an 
age-related increase in in-hospital mortality rate.37
In fact, the impact of sex on mortality rate in STEMI 
is still controversial. Disease registries, especially 
hospital-based registries, are valuable sources providing 
more reliable information about the epidemiology of 
cardiovascular disease (CVD).38 Thus, this STEMI registry 
may help to prioritize research projects and interventions 
and help policy makers to develop health programs. It may 
result in improving STEMI patients’ health, assists health 
caregivers to revise their medical services, and estimate 
the burden of STEMI. The gender-based differences in in-
hospital mortality in STEMI, may indicate gender based 
differences in access and use of health care services, which 
warrant further considerations. 
Limitations 
The most important limitation of the current study, as an 
observational registry, was that such studies have non-
randomized nature and may not be able to control for the 
effects of cofactors, although the researchers measured 
and controlled for the effects of main confounding 
factors. Furthermore, our data were derived from a single 
center registry; hence, our participants may not be the 
representative of the whole STEMI population. 
Conclusion 
In-hospital mortality was higher in women with STEMI 
than their men counterparts. However, sex alone, was not 
a significant predictor of in-hospital mortality in these 
patients. The gender based differences in in-hospital 
mortality may be explained by the more adverse clinical 
risk profile in women. In general, access and use of health 
care programs need to be improved for women, and 
their CVD risk factors, in particular diabetes, HTN, and 
hypercholesterolemia be modified to in timely manner 
to reduce the gender based gaps in cardiovascular health 
outcomes. 
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